| Literature DB >> 27045412 |
Boshra Hatef1, Ali Ghanjal, Gholam Hossein Meftahi, Ahmadreza Askary-Ashtiani.
Abstract
BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) are subject to progressive reduction of muscle mass and strength. The aim of this study was to assess muscle forces and electromyography (EMG) indices in short and long-term diabetes during an isokinetic exercise.Entities:
Year: 2016 PMID: 27045412 PMCID: PMC5016357 DOI: 10.5539/gjhs.v8n8p210
Source DB: PubMed Journal: Glob J Health Sci ISSN: 1916-9736
Demographic and blood characters of three groups and P value
| Healthy control (N=19) | Short-term T2DM (N=18) | Long-term T2DM (N=12) | P value | |
|---|---|---|---|---|
| Number of cases (Female/Male) | 20 (10/10) | 18 (9/9) | 12 (6/6) | 1 |
| Age (years) | 49.55±10 | 52.11±9.2 | 59.17±7.1 | 0.02 |
| Weight (Kg) | 73.68±7.7 | 77.61±12.5 | 77.72±12.4 | 0.47 |
| Height (cm) | 167.89±9.2 | 164.33±8.3 | 166.09±11 | 0.51 |
| BMI (kg/cm2) | 26.25±3 | 28.71±4.1 | 28.54±3.6 | 0.09 |
| Duration of diabetes (years) | 4.8±2 | 15.5±7 | ||
| Medication (insulin+drugs/drugs) (N of cases) | 1/17 | 3/9 | ||
| PAI (sedentary/poor/fair) (%) | 63.2, 26.3, 10.5 | 66.7, 27.8, 5.6 | 45.5, 54.5,0 | 0.83 |
| ABI | 1.17±0.08 | 1.22±0.09 | 1.14±0.14 | 0.43 |
| HbA1c (%) | 4.7±0.8 | 7.02±1.5 | 7.3±1.4 | 0.000 |
| FBS (mmol/l) | 91±12.6 | 141.65±36.9 | 160.91±31.4 | 0.000 |
| Blood sugar (mmol/l) | 114.05±17.7 | 167.39±44.23 | 205.20±84.24 | 0.000 |
Data are mean±SD.
: Post Hoc between health and long-term T2DM groups,
: Post Hoc between healthy and long-term T2DM and short-term T2DM groups.
FBS: fasting blood sugar
Mean (SD) and P value of two-way ANCOVA of CMPT and two-way ANOVA of slope and fatigue index between three groups and two genders
| Gender | Healthy control (N=19) | short-term T2DM (N=18) | Long-term T2DM (N=12) | p-value | |||
|---|---|---|---|---|---|---|---|
| Group | Gender | Gender×Group | |||||
| Male | 1.43(.24) | .99(.3) | .8(.22) | 0.053 | |||
| Female | .81(.27) | .66(.2) | .53(.09) | ||||
| Male | .79(.22) | .56(.15) | .5(.11) | 0.61 | |||
| Female | .56(.13) | .43(.16) | .36(.09) | ||||
| Male | 60.53(16) | 58.14(13) | 51.17(12) | 0.31 | 0.85 | ||
| Female | 50.13(14) | 45.08(12) | 43.83(12) | ||||
| Male | 63.91(9) | 63.11(8) | 73.11(9) | 0.34 | |||
| Female | 63.01(7) | 52.7(13) | 67.18(4) | ||||
| Male | -.88(.5) | -.89(.4) | -.94(.5) | 0.94 | 0.12 | 0.88 | |
| Female | -1.13(.6) | -1.23(.3) | -1.08(.4) | ||||
| Male | -.73(.4) | -.75(.4) | -.39(.2) | 0.39 | 0.49 | ||
| Female | -.74(.2) | -1.02(.4) | -.4(.1) | ||||
Data are mean (SD) in the descriptive columns and p-value in the analytical columns,
: healthy control and both diabetic groups,
: Post Hoc was significant between long-term and short-term T2DM and
: Post Hoc was significant between long-term T2DM and two other groups.
M: men, W: women, CMPT: concentric maximum peak torque, EXT: extension, FLEX: flexion.
Mean (SD) and P value of three-way mixed model ANOVA of MPF between three groups and two sexes, initial and final part of isokinetic protocol
| EMG | Time | Gender | Groups | P Value | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthy control (N=19) | short-term T2DM (N=18) | Long-term T2DM (N=12) | Time | Group | Gender | Group × Gender | Time × Group | Time × Gender | Time × Group × Gender | ||||
| 66.52(7) | 67.65(14) | 71.95(12) | 0.53 | 0.83 | 0.93 | 0.77 | 0.82 | 0.17 | |||||
| 65.92(14) | 72.35(9) | 69.41(17) | |||||||||||
| 54.25(7) | 58.95(15) | 57.4(9) | |||||||||||
| 55.39(10) | 59.21(8) | 58.7(14) | |||||||||||
| 76.28(9) | 72.51(14) | 74.74(3) | 0.43 | 0.32 | 0.35 | 0.57 | 0.93 | 0.60 | |||||
| 73.87(14) | 82.31(8) | 76.65(22) | |||||||||||
| 54.91(3) | 58.08(12) | 58.38(10) | |||||||||||
| 56.57(7) | 65.68(11) | 57.68(10) | |||||||||||
| 85.73(12) | 92.42(29) | 97.48(26) | 0.15 | 0.24 | 0.66 | 0.98 | |||||||
| 86.38(13) | 122.94(9) | 87.49(23) | |||||||||||
| 62.63(12) | 64.02(10) | 81.48(20) | |||||||||||
| 66.54(7) | 95.84(11) | 74.53(13) | |||||||||||
| 75.9(9) | 92.99(21) | 74.73(8) | 0.20 | 0.30 | 0.49 | 0.11 | 0.72 | ||||||
| 83.86(18) | 88.19(19) | 74.63(14) | |||||||||||
| 52.86(7) | 63.06(20) | 64.69(7) | |||||||||||
| 67.9(16) | 70.31(14) | 67.2(14) | |||||||||||
Data are mean (SD) in the descriptive columns and p-value in the analytical columns,
: Post Hoc was significant between healthy control and short-term T2DM.
Mean (SD) and P value of three-way mixed model ANOVA of RMS between three groups and two sexes, initial and final part of isokinetic protocol
| EMG | Time | Gender | Groups | P Value | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthy control (N=19) | short-term T2DM (N=18) | Long-term T2DM (N=12) | Time | Group | Gender | Group × Gender | Time × Group | Time × Gender | Time × Group × Gender | ||||
| 353.21(98) | 264.66(110) | 233.15(79) | 0.59 | 0.72 | |||||||||
| 240.48(118) | 204.71(161) | 97.5(33) | |||||||||||
| 410.78(97) | 284.24(110) | 276.14(100) | |||||||||||
| 273.78(140) | 213.42(180) | 109.56(30) | |||||||||||
| 210(62) | 158.98(45) | 172.74(51) | 0.083 | 0.59 | 0.36 | 0.60 | |||||||
| 120.97(49) | 104.19(50) | 78.67(29) | |||||||||||
| 244.98(80) | 182.19(70) | 158.78(42) | |||||||||||
| 135.02(63) | 111.82(72) | 71(22) | |||||||||||
| 177.43(75) | 97.85(41) | 123.12(44) | 0.60 | 0.15 | 0.72 | 0.72 | 0.76 | 0.83 | |||||
| 137.21(29) | 97.92(57) | 74.79(31) | |||||||||||
| 180.22(87) | 95.42(35) | 118.91(31) | |||||||||||
| 137.64(32) | 82.17(51) | 75.68(38) | |||||||||||
| 259.56(94) | 153.17(78) | 142.24(47) | 0.089 | 0.75 | 0.46 | 0.15 | |||||||
| 163(64) | 113.89(64) | 75.75(6) | |||||||||||
| 272.33(104) | 198.42(115) | 146.76(57) | |||||||||||
| 164(75) | 106.18(64) | 75.98(22) | |||||||||||
Data are mean (SD) in the descriptive columns and p-value in the analytical columns,
: Post Hoc was significant between healthy control and both diabetic,
: Post Hoc was significant between healthy control and long-term T2DM and
: Post Hoc was significant between long-term T2DM and two other groups.